Showing results (131-140 of 216) with videos related to
Sort By:
Pageof 22
Research and Practice in Thrombosis and Haemostasis|March 4, 2024
Acquired hemophilia A: a single-center study of 165 patientsDandan Yu, Feng Xue, Xiaofan Liu, et al.Research and Practice in Thrombosis and Haemostasis|September 30, 2024
A single-center study of patients with rare isolated acquired clotting factor deficiencies other than acquired hemophilia ADandan Yu, Feng Xue, Xiaofan Liu, et al.Clinical Immunology (Orlando, Fla.)|June 16, 2006
Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpuraHe Ren, Hui Zhao, Tingting Wang, et al.Medicine|May 25, 2021
First open-label, single-arm, prospective study of real-world use of FIX replacement therapy in a predominantly pediatric hemophilia B population in ChinaRenchi Yang, Runhui Wu, Jing Sun, et al.European Journal of Haematology|January 28, 2014
External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patientsRongfeng Fu, Min Xuan, Cuicui Lv, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 15, 2021
Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia AYongqiang Zhao, Yu Hu, Jie Jin, et al.Journal of Clinical Immunology|April 26, 2008
Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese populationZhenping Chen, Zeping Zhou, Xiaoli Chen, et al.Carcinogenesis|March 15, 2008
Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)Zhi-Bo Han, He Ren, Hui Zhao, et al.Current Medical Research and Opinion|March 23, 2017
Long-term efficacy and safety of prophylaxis with recombinant factor VIII in Chinese pediatric patients with hemophilia A: a multi-center, retrospective, non-interventional, phase IV (ReCARE) studyChanggang Li, Xinsheng Zhang, Yongqiang Zhao, et al.Biomed Research International|April 28, 2020
Levels of Soluble CD30 and CD26 and Their Clinical Significance in Patients with Primary Immune ThrombocytopeniaHonghui Wang, Xueping Gu, Huiyuan Li, et al.Pageof 22